AAAAAA
Results: 51-75/138
Authors:
SHEARER GM
CLERICI M
Citation: Gm. Shearer et M. Clerici, PROTECTIVE IMMUNITY AGAINST HIV-INFECTION - HAS NATURE DONE THE EXPERIMENT FOR US, Immunology today, 17(1), 1996, pp. 21-24
Authors:
BERETTA A
FURCI L
BURASTERO S
COSMA A
DINELLI ME
LOPALCO L
DESANTIS C
TAMBUSSI G
CARROW E
SABBATANI S
CLERICI M
LAZZARIN A
SICCARDI AG
Citation: A. Beretta et al., HIV-1-SPECIFIC IMMUNITY IN PERSISTENTLY SERONEGATIVE INDIVIDUALS AT HIGH-RISK FOR HIV-INFECTION, Immunology letters, 51(1-2), 1996, pp. 39-43
Authors:
CLERICI M
SHEARER GM
Citation: M. Clerici et Gm. Shearer, CORRELATES OF PROTECTION IN HIV-INFECTION AND THE PROGRESSION OF HIV-INFECTION TO AIDS, Immunology letters, 51(1-2), 1996, pp. 69-73
Authors:
SHEARER GM
CLERICI M
Citation: Gm. Shearer et M. Clerici, RETHINKING AIDS AND CANCER, Science, 274(5285), 1996, pp. 163-164
Authors:
LEWIS LL
VENZON D
CHURCH J
FARLEY M
WHEELER S
KELLER A
RUBIN M
YUEN G
MUELLER B
SLOAS M
WOOD L
BALIS F
SHEARER GM
BROUWERS P
GOLDSMITH J
PIZZO PA
ANDERSON B
HIRSCHFELD S
SEI S
ZEICHNER S
ROILIDES E
CLERICI M
WELLS M
STOCKER V
HIGHAM C
TOWNLEY E
WALSEK C
ZWERSKI S
HEILMAN N
SELKINGUTMAN G
WOLTERS P
MOSS H
JAROSINSKI P
Citation: Ll. Lewis et al., LAMIVUDINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I II STUDY/, The Journal of infectious diseases, 174(1), 1996, pp. 16-25
Authors:
CHOUGNET C
WYNN TA
CLERICI M
LANDAY AL
KESSLER HA
RUSNAK J
MELCHER GP
SHER A
SHEARER GM
Citation: C. Chougnet et al., MOLECULAR ANALYSIS OF DECREASED INTERLEUKIN-12 PRODUCTION IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 174(1), 1996, pp. 46-53
Authors:
LANDAY AL
CLERICI M
HASHEMI F
KESSLER H
BERZOFSKY JA
SHEARER GM
Citation: Al. Landay et al., IN-VITRO RESTORATION OF T-CELL IMMUNE FUNCTION IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PERSONS - EFFECTS OF INTERLEUKIN (IL)-12 AND ANTI-IL-10, The Journal of infectious diseases, 173(5), 1996, pp. 1085-1091
Authors:
BERETTA A
WEISS SH
RAPPOCCIOLO G
MAYUR R
DESANTIS C
QUIRINALE J
COSMA A
ROBBIONI P
SHEARER GM
BERZOFSKY JA
VILLA ML
SICCARDI AG
CLERICI M
Citation: A. Beretta et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SERONEGATIVE INJECTION-DRUG USERS AT RISK FOR HIV EXPOSURE HAVE ANTIBODIES TO HLA CLASS-I ANTIGENS AND T-CELLS SPECIFIC FOR HIV ENVELOPE, The Journal of infectious diseases, 173(2), 1996, pp. 472-476
Authors:
NORBIATO G
BEVILACQUA M
VAGO T
CLERICI M
Citation: G. Norbiato et al., GLUCOCORTICOIDS AND INTERFERON-ALPHA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The Journal of clinical endocrinology and metabolism, 81(7), 1996, pp. 2601-2606
Authors:
SUPINO R
CROSTI M
CLERICI M
WARLTERS A
CLERIS L
ZUNINO F
FORMELLI F
Citation: R. Supino et al., INDUCTION OF APOPTOSIS BY FENRETINIDE (4HPR) IN HUMAN OVARIAN-CARCINOMA CELLS AND ITS ASSOCIATION WITH RETINOIC ACID RECEPTOR EXPRESSION, International journal of cancer, 65(4), 1996, pp. 491-497
Authors:
MARZI M
VIGANO A
TRABATTONI D
VILLA ML
SALVAGGIO A
CLERICI E
CLERICI M
Citation: M. Marzi et al., CHARACTERIZATION OF TYPE-1 AND TYPE-2 CYTOKINE PRODUCTION PROFILE IN PHYSIOLOGICAL AND PATHOLOGICAL HUMAN-PREGNANCY, Clinical and experimental immunology, 106(1), 1996, pp. 127-133
Authors:
ZANUSSI S
SIMONELLI C
DANDREA M
CAFFAU C
CLERICI M
TIRELLI U
DEPAOLI P
Citation: S. Zanussi et al., CD8(-TERM NONPROGRESSOR AND IN PROGRESSOR PATIENTS WITH HIV-1 INFECTION() LYMPHOCYTE PHENOTYPE AND CYTOKINE PRODUCTION IN LONG), Clinical and experimental immunology, 105(2), 1996, pp. 220-224
Authors:
TSUKUI T
HILDESHEIM A
SCHIFFMAN MH
LUCCI J
CONTOIS D
LAWLER P
RUSH BB
LORINCZ AT
CORRIGAN A
BURK RD
QU WM
MARSHALL MA
MANN D
CARRINGTON M
CLERICI M
SHEARER GM
CARBONE DP
SCOTT DR
HOUGHTEN RA
BERZOFSKY JA
Citation: T. Tsukui et al., INTERLEUKIN-2 PRODUCTION IN-VITRO BY PERIPHERAL LYMPHOCYTES IN RESPONSE TO HUMAN PAPILLOMAVIRUS-DERIVED PEPTIDES - CORRELATION WITH CERVICAL PATHOLOGY, Cancer research, 56(17), 1996, pp. 3967-3974
Authors:
CLERICI M
BALOTTA C
SALVAGGIO A
RIVA C
TRABATTONI D
PAPAGNO L
BERLUSCONI A
RUSCONI S
VILLA ML
MORONI M
GALLI M
Citation: M. Clerici et al., HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PHENOTYPE AND INTERLEUKIN-2 INTERLEUKIN-10 RATIO ARE ASSOCIATED MARKERS OF PROTECTION AND PROGRESSION INHIV-INFECTION/, Blood, 88(2), 1996, pp. 574-579
Authors:
CLERICI M
SHEARER GM
Citation: M. Clerici et Gm. Shearer, THE T-HELPER CELL SHIFT IN AIDS - SIGNIFICANCE FOR PHARMACOTHERAPY, CLINICAL IMMUNOTHERAPEUTICS, 3(2), 1995, pp. 95-101
Authors:
BRAMBILLA L
LABIANCA R
FOSSATI S
BONESCHI V
FERRUCCI S
CLERICI M
DALLAVALLE G
Citation: L. Brambilla et al., VINORELBINE - AN ACTIVE-DRUG IN MEDITERRANEAN KAPOSIS-SARCOMA, EJD. European journal of dermatology, 5(6), 1995, pp. 467-469
Authors:
CLERICI M
VILLA ML
TRABATTONI D
SHEARER GM
Citation: M. Clerici et al., THE BREAKDOWN OF THE CYTOKINE NETWORK SUBSEQUENT TO HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Mediators of inflammation, 4(5), 1995, pp. 315-321
Authors:
TEDESCHI L
LOCATELLI C
DANTONA A
CLERICI M
ROMANELLI A
LUPORINI G
Citation: L. Tedeschi et al., EVALUATION OF INCIDENCE OF CISPLATIN (CDDP) - ANEMIA DEVELOPED IN 3 SUBSETS OF NEOPLASTIC PATIENTS (PTS), European journal of cancer, 31A, 1995, pp. 250-250
Authors:
CRINO L
SEAGLIOTTI G
MARANGOLO M
FIGOLI F
CLERICI M
DEMARINIS F
SALVATI F
CRUCIANI G
DOGLIOTTI L
COCCONI G
PACCAGNELLA A
ADAMO V
INCORONATO P
SCARCELLA L
MOSCONI AM
TONATO M
Citation: L. Crino et al., GEMCITABINE-CISPLATIN COMBINATION IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY, European journal of cancer, 31A, 1995, pp. 1064-1064
Authors:
CRINO L
CLERICI M
FIGOLI F
CARLINI P
CECI G
CORTESI E
CARPI A
SANTINI A
DICOSTANZO F
BONI C
MEACCI M
CORGNA E
DARWISH S
SCARCELLA L
SANTUCCI A
BALLATORI E
Citation: L. Crino et al., CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), Annals of oncology, 6(4), 1995, pp. 347-353
Authors:
CHOUGNET C
CLERICI M
SHEARER GM
Citation: C. Chougnet et al., ROLE OF IL12 IN HIV DISEASE AIDS, Research in immunology, 146(7-8), 1995, pp. 615-619
Authors:
ZEHENDER G
MERONI L
PICONI S
DEMADDALENA C
PARRAVICINI C
CLERICI M
RIDOLFO AL
MORONI M
GALLI M
Citation: G. Zehender et al., FREQUENT DETECTION OF ANTIBODIES AGAINST HTLV ANTIGENS IN PATIENTS WITH AIDS-RELATED NON-HODGKIN-LYMPHOMA, AIDS research and human retroviruses, 11(7), 1995, pp. 823-827
Authors:
SHEARER GM
CLERICI M
Citation: Gm. Shearer et M. Clerici, PROTECTIVE IMMUNITY AGAINST HIV AIDS, AIDS research and human retroviruses, 11, 1995, pp. 131-131
Authors:
MERONI L
TRABATTONI D
BALOTTA C
RIVA C
GORI A
MORONI M
VILLA ML
CLERICI M
GALLI M
Citation: L. Meroni et al., TYPE-2 CYTOKINE PROFILE AND T-LYMPHOCYTE ACTIVATION IN RECENTLY SEROCONVERTED HIV-1-INFECTED SUBJECTS, AIDS research and human retroviruses, 11, 1995, pp. 148-148
Authors:
NGUYEN BY
CLERICI M
BAUZA S
BAILEY J
LONGO D
MURPHY W
GESUNDHEIT N
VENZON D
SHEARER G
YARCHOAN R
Citation: By. Nguyen et al., IMMUNOLOGICAL EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR(RHIGF-1) AND RECOMBINANT HUMAN GROWTH-HORMONE (RHGH) IN HIV-INFECTEDPATIENTS, AIDS research and human retroviruses, 11, 1995, pp. 164-164